If you're excited about the nation's long-term prospects, Cramer has an idea for your portfolio.» Read More
Fund managers' short gold bets hit record levels, with the Fast Money traders. Trader Tim Seymour says gold "no longer a crowded trade."
Hedge funds are the most bullish they've been in about six years. Find out the top 10 stocks they love.
Wells Fargo's valuation to the consensus forward earnings estimate is only slightly above the rest of the "big four" U.S. banks, despite being the strongest and steadiest earner among the group for many years. TheStreet.com reports.
Software giant Oracle has pulled back, and the bulls are stepping in.
The "Mad Money" host reveals what he plans to follow in the days to come.
Analysts at Citi benched a major player in their latest ranking of so-called world champion stocks.
A slower period for the economy may be a serious headwind for stocks.
Automatic Data Processing pulled back yesterday, and the bulls stepped in.
Jim Cramer is taking the Pepsi Challenge. Which stock does he prefer?
The Fast Money crew offers special CNBC.com-only advice on your investments.
"I don't expect a crash. But I think for the time being, the market has peaked out" and "bonds, which are extremely oversold, could rebound," Faber said on CNBC.
Investors are increasingly worried about the health of their portfolios but CNBC's Jim Cramer thinks some of these worries are overblown.
Shares of Darden Restaurants have been declining since last fall, and the bears apparently want to send the stock even lower.
Although Apple shares are trading near 52-week lows, one analyst still thinks the tech giant is a "strong buy" for investors. Here's why.
Based on a proprietary algorithm from Chartlab Pro, here are the 10 most overbought stocks in the market right now.
While the S&P 500 has climbed 11.75 percent in the past three months, the health care sector has only managed to muster a 2.3 percent climb over the same time period. But underperformance tends to be cyclical.
In a market environment littered with deals, CNBC's Jim Cramer sees a growing divergence between market pros on the bullish and bearish ends of the spectrum.
Sarepta Therapeutics has been holding its ground for months, and now the bulls are looking for the next leg higher.
Gas prices aren't likely to continue their upward trajectory, Dennis Gartman says.
Stick with what works, Oppenheimer's John Stoltzfus says.